The splicing regulator protein Tra2β also increases the expression in prostate cancer tissues, and this is associated with preoperative prostate-specific antigen, lymph node metastasis, clinical stage, Gleason score and biochemical recurrence (Diao et al. 2015). The gene discussed is TRA2B; the disease is prostate cancer.